Jmjd2c maintains the ALDH^bri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma

References

• Yuan X, He J, Sun F, Gu J. Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2013;6(12):2651–11.
   PubMed Web of Science ®Google Scholar
• Li Y, Gu J, Xu F, Zhu Q, Ge D, Lu C. Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data. Sci Rep. 2018;8(1):15834. doi:10.1038/s41598-018-34160-w.
   PubMed Web of Science ®Google Scholar
• Chen JW, Dhahbi J. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods. Sci Rep. 2021;11(1):13323. doi:10.1038/s41598-021-92725-8.
   PubMed Web of Science ®Google Scholar
• Xue Y, Gao S, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X, Wu R. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action. Expert Opin Drug Deliv. 2021;18(2):187–203. doi:10.1080/17425247.2021.1825376.
   PubMed Web of Science ®Google Scholar
• Croagh D, Thomas RJ, Phillips WA, Kaur P. Esophageal stem cells—a review of their identification and characterization. Stem Cell Rev. 2008;4(4):261–68. doi:10.1007/s12015-008-9031-3.
   PubMedGoogle Scholar
• Miranda Furtado CL, Dos Santos Luciano MC, Silva Santos RD, Furtado GP, Moraes MO, Pessoa C. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenet. 2019;14(12):1164–76. doi:10.1080/15592294.2019.1640546.
   PubMed Web of Science ®Google Scholar
• Zhao L, Duan YT, Lu P, Zhang ZJ, Zheng XK, Wang JL, Feng WS. Epigenetic targets and their inhibitors in cancer therapy. Curr Top Med Chem. 2018;18(28):2395–419. doi:10.2174/1568026619666181224095449.
   PubMed Web of Science ®Google Scholar
• Nebbioso A, Tambaro FP, Dell’aversana C, Altucci L, Greally JM. Cancer epigenetics: moving forward. PloS Genet. 2018;14(6):e1007362. doi:10.1371/journal.pgen.1007362.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3–55.
   PubMed Web of Science ®Google Scholar
• Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, et al. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. J Cell Physiol. 2007;212(2):330–44. doi:10.1002/jcp.21066.
   PubMed Web of Science ®Google Scholar
• Perillo B, Tramontano A, Pezone A, Migliaccio A. LSD1: more than demethylation of histone lysine residues. Experiment Molecul Med. 2020;52(12):1936–47. doi:10.1038/s12276-020-00542-2.
   PubMed Web of Science ®Google Scholar
• Yang J, Hu Y, Zhang B, Liang X, Li X. The JMJD family histone demethylases in crosstalk between inflammation and cancer. Front Immunol. 2022;13:881396. doi:10.3389/fimmu.2022.881396.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Huang J, Shi T, Ma X, Luo X, Li X, Li M. Inhibiting Jumoji domain containing protein 3 (JMJD3) prevent neuronal apoptosis from stroke. Exp Neurol. 2018;308:132–42. doi:10.1016/j.expneurol.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, Sugano S, Nakamura Y, Inazawa J. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 2000;60(17):4735–39.
   PubMed Web of Science ®Google Scholar
• Hyun K, Jeon J, Park K, Kim J. Writing, erasing and reading histone lysine methylations. Experim Molecul Med. 2017;49(4):e324. doi:10.1038/emm.2017.11.
   PubMed Web of Science ®Google Scholar
• Tomaz RA, Harman JL, Karimlou D, Weavers L, Fritsch L, Bou-Kheir T, Bell E, Del Valle Torres I, Niakan KK, Fisher C, et al. Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation. Develop. 2017;144(4):567–79. doi:10.1242/dev.142489.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang Z, Ji Q, Li Q. Histone demethylase JMJD2C: epigenetic regulators in tumors. Oncotarget. 2017;8(53):91723–33. doi:10.18632/oncotarget.19176.
   PubMedGoogle Scholar
• Li X, Dong S. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma. Med Oncol. 2015;32(3):53. doi:10.1007/s12032-015-0503-4.
   PubMed Web of Science ®Google Scholar
• An Y, Cai H, Zhang Y, Liu S, Duan Y, Sun D, Chen X, He X. circZMYM2 competed endogenously with miR-335-5p to regulate JMJD2C in pancreatic cancer. Cell Physiol Biochem. 2018;51(5):2224–36. doi:10.1159/000495868.
   PubMedGoogle Scholar
• Hong Q, Yu S, Yang Y, Liu G, Shao Z. A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer. Oncotarget. 2014;5(13):4779–87. doi:10.18632/oncotarget.2029.
   PubMedGoogle Scholar
• Li N, Jiang D. Jumonji domain containing 2C promotes cell migration and invasion through modulating CUL4A expression in lung cancer. Biomed Pharmacother. 2017;89:305–15. doi:10.1016/j.biopha.2017.02.014.
   PubMed Web of Science ®Google Scholar
• Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauss A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11:1280. doi:10.3389/fimmu.2020.01280.
   PubMed Web of Science ®Google Scholar
• Kusoglu A, Biray Avci Ç. Cancer stem cells: a brief review of the current status. Gene. 2019;681:80–85. doi:10.1016/j.gene.2018.09.052.
   PubMed Web of Science ®Google Scholar
• Dawood S, Austin L, Cristofanilli M. Cancer stem cells: implications for cancer therapy. Oncol (Williston Park). 2014;28(12):1101–7, 1110.
   PubMed Web of Science ®Google Scholar
• Porter L, McCaughan F. SOX2 and squamous cancers. Semin Cancer Biol. 2020;67(Pt 1):154–67. doi:10.1016/j.semcancer.2020.05.007.
   PubMedGoogle Scholar
• Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, Zheng H. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12(5):449. doi:10.1038/s41419-021-03733-5.
   PubMed Web of Science ®Google Scholar
• Chen X, Xie R, Gu P, Huang M, Han J, Dong W, Xie W, Wang B, He W, Zhong G, et al. Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2. Clin Cancer Res. 2019;25(4):1389–403. doi:10.1158/1078-0432.CCR-18-1656.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40–46. doi:10.1097/CCO.0000000000000703.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr., Wu YL, Paz-Ares L. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311. doi:10.1016/S0140-6736(16)30958-8.
   PubMed Web of Science ®Google Scholar
• Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008;5(10):588–99. doi:10.1038/ncponc1187.
   PubMedGoogle Scholar
• Zhang J, Wang M, Wang J, Wang W. JMJD2C-mediated long non-coding RNA MALAT1/microRNA-503-5p/SEPT2 axis worsens non-small cell lung cancer. Cell Death Dis. 2022;13(1):65. doi:10.1038/s41419-022-04513-5.
   PubMed Web of Science ®Google Scholar
• Najafi M, Mortezaee K, Majidpoor J. Cancer stem cell (CSC) resistance drivers. Life Sci. 2019;234:116781. doi:10.1016/j.lfs.2019.116781.
   PubMed Web of Science ®Google Scholar
• Peiris-Pages M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Res. 2016;18(1):55. doi:10.1186/s13058-016-0712-6.
   PubMedGoogle Scholar
• Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012;48(4):491–507. doi:10.1016/j.molcel.2012.11.006.
   PubMed Web of Science ®Google Scholar
• Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439(7078):811–16. doi:10.1038/nature04433.
   PubMed Web of Science ®Google Scholar
• Novak D, Huser L, Elton JJ, Umansky V, Altevogt P, Utikal J. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67(Pt 1):74–82. doi:10.1016/j.semcancer.2019.08.007.
   PubMedGoogle Scholar
• Funaya S, Aoki F. Regulation of zygotic gene activation by chromatin structure and epigenetic factors. J Reprod Dev. 2017;63(4):359–63. doi:10.1262/jrd.2017-058.
   PubMed Web of Science ®Google Scholar
• Lawrence M, Daujat S, Schneider R. Lateral thinking: How histone modifications regulate gene expression. Trends Genet. 2016;32(1):42–56. doi:10.1016/j.tig.2015.10.007.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Zhang W, Chen Y, Han X, Li J, Zhang Y, Zhang Y, Zhang S, Liu B. Doxorubicin-enriched, ALDHbr mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1. BMC Cancer. 2012;12(1):549. doi:10.1186/1471-2407-12-549.
   PubMedGoogle Scholar